(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in Turkey.
(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in Turkey.
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2023 Scienmag- Science Magazine: Latest Science News.
© 2023 Scienmag- Science Magazine: Latest Science News.